Spatacsin inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of spatacsin, a protein encoded by the SPG11 gene, which plays a crucial role in the maintenance and function of the nervous system, particularly in axonal transport and lysosomal function. Spatacsin is involved in the formation and function of a complex responsible for the trafficking and processing of lysosomes, which are essential organelles for cellular waste degradation and recycling. This protein is particularly important in neurons, where proper lysosomal function is critical for the maintenance of long axons and the overall health of nerve cells. By inhibiting spatacsin, researchers can disrupt these vital cellular processes, offering a tool to study the specific contributions of spatacsin to neuronal function, intracellular transport, and lysosomal dynamics.
In research settings, spatacsin inhibitors are valuable tools for exploring the molecular mechanisms by which spatacsin regulates lysosomal function and axonal maintenance, and the broader implications of its activity on neuronal health and function. By blocking spatacsin activity, scientists can investigate how the inhibition affects lysosomal trafficking, the degradation of cellular waste, and the maintenance of axonal integrity. This inhibition allows researchers to study the downstream effects on neuronal function, including potential disruptions in axonal transport, accumulation of undegraded cellular components, and the impact on overall neuronal health. Additionally, spatacsin inhibitors provide insights into the interactions between spatacsin and other proteins involved in lysosomal function and axonal transport, shedding light on the complex regulatory networks that ensure the proper functioning of neurons and the maintenance of cellular homeostasis. Through these studies, the use of spatacsin inhibitors enhances our understanding of the critical role of lysosomal dynamics in neuronal function, the regulation of intracellular transport, and the broader implications of these processes for cellular health and neurodegeneration.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Inhibits ATP synthase in mitochondria, indirectly affecting proteins like Spatacsin that are involved in ATP-dependent processes. | ||||||
Carbonyl Cyanide m-Chlorophenylhydrazone | 555-60-2 | sc-202984A sc-202984 sc-202984B | 100 mg 250 mg 500 mg | $77.00 $153.00 $240.00 | 8 | |
Uncouples oxidative phosphorylation, which could disrupt mitochondrial functions and indirectly affect Spatacsin activity. | ||||||
Tizanidine-d4 | 64461-82-1 (unlabeled) | sc-220264 | 1 mg | $330.00 | ||
An alpha2-adrenergic agonist that can help relieve muscle spasticity. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Inhibits mitochondrial complex I, which could indirectly affect Spatacsin's role in mitochondrial function. | ||||||
Paraquat chloride | 1910-42-5 | sc-257968 | 250 mg | $168.00 | 7 | |
Induces oxidative stress within mitochondria, potentially affecting proteins involved in mitochondrial quality control, such as Spatacsin. | ||||||
Xanthohumol from hop (Humulus lupulus) | 6754-58-1 | sc-301982 | 5 mg | $361.00 | 1 | |
Inhibits ATP synthase, could indirectly affect Spatacsin activity by altering ATP availability in mitochondria. | ||||||
Dantrolene | 7261-97-4 | sc-500165 | 25 mg | $350.00 | 7 | |
Helps in managing spasticity by acting directly on skeletal muscles. | ||||||
Mito-Q | 444890-41-9 | sc-507441 | 5 mg | $290.00 | ||
Targets mitochondria and modulates redox status, which may influence Spatacsin function indirectly through oxidative stress mechanisms. | ||||||
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | $43.00 $104.00 $328.00 | 3 | |
Acts on the mitochondrial electron transport chain, potentially altering mitochondrial function and indirectly affecting Spatacsin. | ||||||
Gabapentin | 60142-96-3 | sc-201481 sc-201481A sc-201481B | 20 mg 100 mg 1 g | $53.00 $94.00 $135.00 | 7 | |
Used for neuropathic pain, which can be a symptom in some HSP patients. | ||||||